Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease hepatocellular carcinoma
Symptom C0020541|portal hypertension
Sentences 9
PubMedID- 25212123 portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: a systematic review and meta-analysis.
PubMedID- 24670026 The outcome of liver resection (lr) for elderly hepatocellular carcinoma (hcc) patients with portal hypertension (pht) who may be excluded as liver transplantation candidates has not been fully evaluated.
PubMedID- 25532502 Advanced liver fibrosis usually proceeds to cirrhosis and even hepatocellular carcinoma, leading to liver failure, portal hypertension and even death.
PubMedID- 25700311 Hepatic resection for hepatocellular carcinoma in patients with portal hypertension: a long-term benefit compared with transarterial chemoembolization and thermal ablation.
PubMedID- 25457251 Background: to assess the effects of various operations for hepatocellular carcinoma with portal hypertension (ph).
PubMedID- 26124358 Splenectomy followed by hepatectomy for hepatocellular carcinoma with hypersplenism and portal hypertension caused by macroglobulinemia.
PubMedID- 25958066 Resection versus ablation in hepatitis b virus-related hepatocellular carcinoma patients with portal hypertension: a propensity score matching study.
PubMedID- 25598405 portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: a systematic review and meta-analysis.
PubMedID- 24867654 We report a systematic review and meta-analysis to determine the impact of clinically significant portal hypertension on survival in patients with hepatocellular carcinoma (hcc) following hepatectomy.

Page: 1